Nintedanib
Cat. No.:YN440409
产品名称: | Nintedanib |
CAS No.: | 656247-17-5 |
Chemical Name: | (3Z)-2,3-dihydro-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-1H-indole-6-carboxylic acid, methyl ester |
Synonyms: | 尼达尼布; BIBF 1120 |
分子量: | 539.62 |
分子式: | C₃₁H₃₃N₅O₄ |
SMILES: | O=C1NC2=CC(C(OC)=O)=CC=C2/C1=C(NC3=CC=C(N(C(CN4CCN(C)CC4)=O)C)C=C3)\C5=CC=CC=C5 |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | Nintedanib (BIBF 1120) 是一种有效的三重血管激酶抑制剂,抑制VEGFR1/2/3,FGFR1/2/3和PDGFRα/β的IC50值分别为 34 nM/13 nM/13 nM,69 nM/37 nM/108 nM 和 59 nM/65 nM。 |
IC50和靶点: | [{name:"VEGFR1:34 nM (IC50)"},{name: "VEGFR2:13 nM (IC50)"},{name: "VEGFR3:13 nM (IC50)"},{name: "FGFR1:69 nM (IC50)"},{name: "FGFR2:37 nM (IC50)"},{name: "FGFR3:108 nM (IC50)"},{name: "PDGFRα:59 nM (IC50)"},{name: "PDGFRβ:65 nM (IC50)"}] |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Hilberg, F., Roth, G.J., Krssak, M., et al.BIBF 1120: Triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacyCancer Res.68(12),4774-4782(2008)